Income Statement

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Operating expenses:        
Research and development $ 2,426,600 $ 1,606,100 $ 3,522,800 $ 2,431,800
General and administrative 2,567,100 1,493,600 3,731,400 2,631,200
Total operating expenses 4,993,700 3,099,700 7,254,200 5,063,000
Loss from operations (4,993,700) (3,099,700) (7,254,200) (5,063,000)
Other expenses, net:        
Interest expense, net (3,300) (1,400) (5,700) (2,800)
Loss before income taxes (4,997,000) (3,101,100) (7,259,900) (5,065,800)
Income taxes 0 0 (2,400) (2,400)
Net loss (4,997,000) (3,101,100) (7,262,300) (5,068,200)
Accrued dividends on Series B Preferred stock (256,300) (241,000) (503,600) (780,800)
Deemed dividend on Series B Preferred Units 0 0 0 (111,100)
Net loss attributable to common stockholders $ (5,253,300) $ (3,342,100) $ (7,765,900) $ (5,960,100)
Basic and diluted net loss attributable to common stockholders per common share $ (0.53) $ (0.42) $ (0.82) $ (0.91)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 9,892,016 8,041,619 9,465,459 6,577,769

Source